Black men with advanced prostate cancer less likely to receive crucial treatment, study finds. UCLA-led study shows Black men are 24% less likely to be prescribed novel hormone therapy compared to white men.
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups – including white or Latino men – despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.
Black men with advanced prostate cancer less likely to receive crucial treatment, study finds medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
A recent meta-analysis addresses controversies surrounding the relevance of biochemical recurrence (BCR) as a surrogate endpoint for overall survival in trials of localized disease.